Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Ophtadoc AB
AB
Active
Org 5590513841
Blåsippevägen 9, 589 35
Linköping
Medical specialists activities
·
NACE 8622
Est. 2016 · 10 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Medical specialists activities
/
Ophtadoc AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
9M
7M
4M
2M
0M
2021: 4M
4M
2021
2022: 4M (0% vs 2021)
4M
0%
2022
2023: 5M (+25% vs 2022)
5M
+25%
2023
2024: 7M (+40% vs 2023)
7M
+40%
2024
2025: 7M (0% vs 2024)
7M
0%
2025
EBITDA
SEK millions
6M
5M
3M
2M
0M
2021: 2M
2M
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 3M (+50% vs 2022)
3M
+50%
2023
2024: 2M (-33% vs 2023)
2M
-33%
2024
2025: 5M (+150% vs 2024)
5M
+150%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
7 252
7 331
5 335
4 154
3 706
Staff expenses
—
—
—
—
—
EBITDA
5 234
2 115
3 173
1 996
1 557
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
5 234
2 115
3 173
1 996
1 557
Net financials
429
−20
34
356
−1
Profit before tax
4 494
1 920
2 560
1 890
1 165
Tax
−936
−426
−544
−369
−243
Net profit
3 558
1 494
2 016
1 521
922
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
12 395
9 458
8 381
5 967
4 473
Equity
6 799
4 973
4 145
2 793
1 937
Long-term debt
0
0
0
0
0
Short-term debt
1 160
1 218
1 144
729
555
Total debt
1 160
1 218
1 144
729
555
Financial ratios
5-year trend
EBITDA margin
72,2 %
This company
15,8 %
Market median
This company
Market median
357% above market
2021
2025
Equity ratio
54,9 %
This company
38,2 %
Market median
This company
Market median
44% above market
2021
2025
Return on equity
52,3 %
This company
18,4 %
Market median
This company
Market median
184% above market
2021
2025
Net profit margin
49,1 %
This company
8,1 %
Market median
This company
Market median
506% above market
2021
2025
Asset turnover
0,59×
This company
1,12×
Market median
This company
Market median
47% below market
2021
2025
Debt / equity
0,82×
This company
0,62×
Market median
This company
Market median
32% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Ophtadoc AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
